The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Post-Traumatic Stress Disorder (PTSD) Market Research Report 2024
Synopsis
Post-traumatic stress disorder (PTSD) is a delayed and persistent mental disorder that occurs when an individual experiences, witnesses, or encounters one or more actual deaths involving himself or others, or is threatened with death, or is severely injured, or whose physical integrity is threatened.The incidence of PTSD has been reported inconsistently, with women more likely to develop PTSD than men.
The global Post-Traumatic Stress Disorder (PTSD) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Post-Traumatic Stress Disorder (PTSD) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Post-Traumatic Stress Disorder (PTSD) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Post-Traumatic Stress Disorder (PTSD) in Children is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Post-Traumatic Stress Disorder (PTSD) include GlaxoSmithKline (UK), Pfizer (US), Eli Lilly and Company (US), Lundbeck A/S (Denmark), Azevan Pharmaceuticals (US), Marinus Pharmaceuticals, Inc. (US), Tonix Pharmaceuticals Holding Corp. (US), Bionomics (Australia) and Greenstone LLC (US), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Post-Traumatic Stress Disorder (PTSD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Post-Traumatic Stress Disorder (PTSD).
Report Scope
The Post-Traumatic Stress Disorder (PTSD) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Post-Traumatic Stress Disorder (PTSD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Post-Traumatic Stress Disorder (PTSD) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline (UK)
Pfizer (US)
Eli Lilly and Company (US)
Lundbeck A/S (Denmark)
Azevan Pharmaceuticals (US)
Marinus Pharmaceuticals, Inc. (US)
Tonix Pharmaceuticals Holding Corp. (US)
Bionomics (Australia)
Greenstone LLC (US)
Mylan NV (US)
Otsuka Pharmaceutical (Japan)
Prometheon Pharma (USA)
Ligand Pharma (USA)
Valenta Pharm (Russia)
Lycera Corp (US)
Archimedes (UK)
GMP Endotherapeutics (USA)
Nuvo Pharmaceuticals (Canada)
Beijing Wansheng Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zhejiang Jianfeng Pharmaceutical
Segment by Type
Cognitive Therapy
Exposure Therapy
Eye Movement Desensitization And Reprocessing (EMDR)
Antidepressants
Anti-Anxiety Medications
Prazosin
Segment by Application
Children
Adult
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Post-Traumatic Stress Disorder (PTSD) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Post-traumatic stress disorder (PTSD) is a delayed and persistent mental disorder that occurs when an individual experiences, witnesses, or encounters one or more actual deaths involving himself or others, or is threatened with death, or is severely injured, or whose physical integrity is threatened.The incidence of PTSD has been reported inconsistently, with women more likely to develop PTSD than men.
The global Post-Traumatic Stress Disorder (PTSD) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Post-Traumatic Stress Disorder (PTSD) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Post-Traumatic Stress Disorder (PTSD) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Post-Traumatic Stress Disorder (PTSD) in Children is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Post-Traumatic Stress Disorder (PTSD) include GlaxoSmithKline (UK), Pfizer (US), Eli Lilly and Company (US), Lundbeck A/S (Denmark), Azevan Pharmaceuticals (US), Marinus Pharmaceuticals, Inc. (US), Tonix Pharmaceuticals Holding Corp. (US), Bionomics (Australia) and Greenstone LLC (US), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Post-Traumatic Stress Disorder (PTSD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Post-Traumatic Stress Disorder (PTSD).
Report Scope
The Post-Traumatic Stress Disorder (PTSD) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Post-Traumatic Stress Disorder (PTSD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Post-Traumatic Stress Disorder (PTSD) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline (UK)
Pfizer (US)
Eli Lilly and Company (US)
Lundbeck A/S (Denmark)
Azevan Pharmaceuticals (US)
Marinus Pharmaceuticals, Inc. (US)
Tonix Pharmaceuticals Holding Corp. (US)
Bionomics (Australia)
Greenstone LLC (US)
Mylan NV (US)
Otsuka Pharmaceutical (Japan)
Prometheon Pharma (USA)
Ligand Pharma (USA)
Valenta Pharm (Russia)
Lycera Corp (US)
Archimedes (UK)
GMP Endotherapeutics (USA)
Nuvo Pharmaceuticals (Canada)
Beijing Wansheng Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zhejiang Jianfeng Pharmaceutical
Segment by Type
Cognitive Therapy
Exposure Therapy
Eye Movement Desensitization And Reprocessing (EMDR)
Antidepressants
Anti-Anxiety Medications
Prazosin
Segment by Application
Children
Adult
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Post-Traumatic Stress Disorder (PTSD) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cognitive Therapy
1.2.3 Exposure Therapy
1.2.4 Eye Movement Desensitization And Reprocessing (EMDR)
1.2.5 Antidepressants
1.2.6 Anti-Anxiety Medications
1.2.7 Prazosin
1.3 Market by Application
1.3.1 Global Post-Traumatic Stress Disorder (PTSD) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Children
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Post-Traumatic Stress Disorder (PTSD) Market Perspective (2019-2030)
2.2 Post-Traumatic Stress Disorder (PTSD) Growth Trends by Region
2.2.1 Global Post-Traumatic Stress Disorder (PTSD) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Post-Traumatic Stress Disorder (PTSD) Historic Market Size by Region (2019-2024)
2.2.3 Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Region (2025-2030)
2.3 Post-Traumatic Stress Disorder (PTSD) Market Dynamics
2.3.1 Post-Traumatic Stress Disorder (PTSD) Industry Trends
2.3.2 Post-Traumatic Stress Disorder (PTSD) Market Drivers
2.3.3 Post-Traumatic Stress Disorder (PTSD) Market Challenges
2.3.4 Post-Traumatic Stress Disorder (PTSD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Post-Traumatic Stress Disorder (PTSD) Players by Revenue
3.1.1 Global Top Post-Traumatic Stress Disorder (PTSD) Players by Revenue (2019-2024)
3.1.2 Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Players (2019-2024)
3.2 Global Post-Traumatic Stress Disorder (PTSD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Post-Traumatic Stress Disorder (PTSD) Revenue
3.4 Global Post-Traumatic Stress Disorder (PTSD) Market Concentration Ratio
3.4.1 Global Post-Traumatic Stress Disorder (PTSD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Post-Traumatic Stress Disorder (PTSD) Revenue in 2023
3.5 Post-Traumatic Stress Disorder (PTSD) Key Players Head office and Area Served
3.6 Key Players Post-Traumatic Stress Disorder (PTSD) Product Solution and Service
3.7 Date of Enter into Post-Traumatic Stress Disorder (PTSD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Post-Traumatic Stress Disorder (PTSD) Breakdown Data by Type
4.1 Global Post-Traumatic Stress Disorder (PTSD) Historic Market Size by Type (2019-2024)
4.2 Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Type (2025-2030)
5 Post-Traumatic Stress Disorder (PTSD) Breakdown Data by Application
5.1 Global Post-Traumatic Stress Disorder (PTSD) Historic Market Size by Application (2019-2024)
5.2 Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Post-Traumatic Stress Disorder (PTSD) Market Size (2019-2030)
6.2 North America Post-Traumatic Stress Disorder (PTSD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2019-2024)
6.4 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Post-Traumatic Stress Disorder (PTSD) Market Size (2019-2030)
7.2 Europe Post-Traumatic Stress Disorder (PTSD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2019-2024)
7.4 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size (2019-2030)
8.2 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2019-2024)
8.4 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size (2019-2030)
9.2 Latin America Post-Traumatic Stress Disorder (PTSD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2019-2024)
9.4 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size (2019-2030)
10.2 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2019-2024)
10.4 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline (UK)
11.1.1 GlaxoSmithKline (UK) Company Detail
11.1.2 GlaxoSmithKline (UK) Business Overview
11.1.3 GlaxoSmithKline (UK) Post-Traumatic Stress Disorder (PTSD) Introduction
11.1.4 GlaxoSmithKline (UK) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
11.1.5 GlaxoSmithKline (UK) Recent Development
11.2 Pfizer (US)
11.2.1 Pfizer (US) Company Detail
11.2.2 Pfizer (US) Business Overview
11.2.3 Pfizer (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.2.4 Pfizer (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
11.2.5 Pfizer (US) Recent Development
11.3 Eli Lilly and Company (US)
11.3.1 Eli Lilly and Company (US) Company Detail
11.3.2 Eli Lilly and Company (US) Business Overview
11.3.3 Eli Lilly and Company (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.3.4 Eli Lilly and Company (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
11.3.5 Eli Lilly and Company (US) Recent Development
11.4 Lundbeck A/S (Denmark)
11.4.1 Lundbeck A/S (Denmark) Company Detail
11.4.2 Lundbeck A/S (Denmark) Business Overview
11.4.3 Lundbeck A/S (Denmark) Post-Traumatic Stress Disorder (PTSD) Introduction
11.4.4 Lundbeck A/S (Denmark) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
11.4.5 Lundbeck A/S (Denmark) Recent Development
11.5 Azevan Pharmaceuticals (US)
11.5.1 Azevan Pharmaceuticals (US) Company Detail
11.5.2 Azevan Pharmaceuticals (US) Business Overview
11.5.3 Azevan Pharmaceuticals (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.5.4 Azevan Pharmaceuticals (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
11.5.5 Azevan Pharmaceuticals (US) Recent Development
11.6 Marinus Pharmaceuticals, Inc. (US)
11.6.1 Marinus Pharmaceuticals, Inc. (US) Company Detail
11.6.2 Marinus Pharmaceuticals, Inc. (US) Business Overview
11.6.3 Marinus Pharmaceuticals, Inc. (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.6.4 Marinus Pharmaceuticals, Inc. (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
11.6.5 Marinus Pharmaceuticals, Inc. (US) Recent Development
11.7 Tonix Pharmaceuticals Holding Corp. (US)
11.7.1 Tonix Pharmaceuticals Holding Corp. (US) Company Detail
11.7.2 Tonix Pharmaceuticals Holding Corp. (US) Business Overview
11.7.3 Tonix Pharmaceuticals Holding Corp. (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.7.4 Tonix Pharmaceuticals Holding Corp. (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
11.7.5 Tonix Pharmaceuticals Holding Corp. (US) Recent Development
11.8 Bionomics (Australia)
11.8.1 Bionomics (Australia) Company Detail
11.8.2 Bionomics (Australia) Business Overview
11.8.3 Bionomics (Australia) Post-Traumatic Stress Disorder (PTSD) Introduction
11.8.4 Bionomics (Australia) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
11.8.5 Bionomics (Australia) Recent Development
11.9 Greenstone LLC (US)
11.9.1 Greenstone LLC (US) Company Detail
11.9.2 Greenstone LLC (US) Business Overview
11.9.3 Greenstone LLC (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.9.4 Greenstone LLC (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
11.9.5 Greenstone LLC (US) Recent Development
11.10 Mylan NV (US)
11.10.1 Mylan NV (US) Company Detail
11.10.2 Mylan NV (US) Business Overview
11.10.3 Mylan NV (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.10.4 Mylan NV (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
11.10.5 Mylan NV (US) Recent Development
11.11 Otsuka Pharmaceutical (Japan)
11.11.1 Otsuka Pharmaceutical (Japan) Company Detail
11.11.2 Otsuka Pharmaceutical (Japan) Business Overview
11.11.3 Otsuka Pharmaceutical (Japan) Post-Traumatic Stress Disorder (PTSD) Introduction
11.11.4 Otsuka Pharmaceutical (Japan) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
11.11.5 Otsuka Pharmaceutical (Japan) Recent Development
11.12 Prometheon Pharma (USA)
11.12.1 Prometheon Pharma (USA) Company Detail
11.12.2 Prometheon Pharma (USA) Business Overview
11.12.3 Prometheon Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Introduction
11.12.4 Prometheon Pharma (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
11.12.5 Prometheon Pharma (USA) Recent Development
11.13 Ligand Pharma (USA)
11.13.1 Ligand Pharma (USA) Company Detail
11.13.2 Ligand Pharma (USA) Business Overview
11.13.3 Ligand Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Introduction
11.13.4 Ligand Pharma (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
11.13.5 Ligand Pharma (USA) Recent Development
11.14 Valenta Pharm (Russia)
11.14.1 Valenta Pharm (Russia) Company Detail
11.14.2 Valenta Pharm (Russia) Business Overview
11.14.3 Valenta Pharm (Russia) Post-Traumatic Stress Disorder (PTSD) Introduction
11.14.4 Valenta Pharm (Russia) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
11.14.5 Valenta Pharm (Russia) Recent Development
11.15 Lycera Corp (US)
11.15.1 Lycera Corp (US) Company Detail
11.15.2 Lycera Corp (US) Business Overview
11.15.3 Lycera Corp (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.15.4 Lycera Corp (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
11.15.5 Lycera Corp (US) Recent Development
11.16 Archimedes (UK)
11.16.1 Archimedes (UK) Company Detail
11.16.2 Archimedes (UK) Business Overview
11.16.3 Archimedes (UK) Post-Traumatic Stress Disorder (PTSD) Introduction
11.16.4 Archimedes (UK) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
11.16.5 Archimedes (UK) Recent Development
11.17 GMP Endotherapeutics (USA)
11.17.1 GMP Endotherapeutics (USA) Company Detail
11.17.2 GMP Endotherapeutics (USA) Business Overview
11.17.3 GMP Endotherapeutics (USA) Post-Traumatic Stress Disorder (PTSD) Introduction
11.17.4 GMP Endotherapeutics (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
11.17.5 GMP Endotherapeutics (USA) Recent Development
11.18 Nuvo Pharmaceuticals (Canada)
11.18.1 Nuvo Pharmaceuticals (Canada) Company Detail
11.18.2 Nuvo Pharmaceuticals (Canada) Business Overview
11.18.3 Nuvo Pharmaceuticals (Canada) Post-Traumatic Stress Disorder (PTSD) Introduction
11.18.4 Nuvo Pharmaceuticals (Canada) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
11.18.5 Nuvo Pharmaceuticals (Canada) Recent Development
11.19 Beijing Wansheng Pharmaceutical
11.19.1 Beijing Wansheng Pharmaceutical Company Detail
11.19.2 Beijing Wansheng Pharmaceutical Business Overview
11.19.3 Beijing Wansheng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Introduction
11.19.4 Beijing Wansheng Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
11.19.5 Beijing Wansheng Pharmaceutical Recent Development
11.20 Zhejiang Huahai Pharmaceutical
11.20.1 Zhejiang Huahai Pharmaceutical Company Detail
11.20.2 Zhejiang Huahai Pharmaceutical Business Overview
11.20.3 Zhejiang Huahai Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Introduction
11.20.4 Zhejiang Huahai Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
11.20.5 Zhejiang Huahai Pharmaceutical Recent Development
11.21 Zhejiang Jianfeng Pharmaceutical
11.21.1 Zhejiang Jianfeng Pharmaceutical Company Detail
11.21.2 Zhejiang Jianfeng Pharmaceutical Business Overview
11.21.3 Zhejiang Jianfeng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Introduction
11.21.4 Zhejiang Jianfeng Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
11.21.5 Zhejiang Jianfeng Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Cognitive Therapy
Table 3. Key Players of Exposure Therapy
Table 4. Key Players of Eye Movement Desensitization And Reprocessing (EMDR)
Table 5. Key Players of Antidepressants
Table 6. Key Players of Anti-Anxiety Medications
Table 7. Key Players of Prazosin
Table 8. Global Post-Traumatic Stress Disorder (PTSD) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Region (2019-2024)
Table 12. Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Region (2025-2030)
Table 14. Post-Traumatic Stress Disorder (PTSD) Market Trends
Table 15. Post-Traumatic Stress Disorder (PTSD) Market Drivers
Table 16. Post-Traumatic Stress Disorder (PTSD) Market Challenges
Table 17. Post-Traumatic Stress Disorder (PTSD) Market Restraints
Table 18. Global Post-Traumatic Stress Disorder (PTSD) Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Players (2019-2024)
Table 20. Global Top Post-Traumatic Stress Disorder (PTSD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post-Traumatic Stress Disorder (PTSD) as of 2023)
Table 21. Ranking of Global Top Post-Traumatic Stress Disorder (PTSD) Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Post-Traumatic Stress Disorder (PTSD) Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Post-Traumatic Stress Disorder (PTSD) Product Solution and Service
Table 25. Date of Enter into Post-Traumatic Stress Disorder (PTSD) Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Type (2019-2024)
Table 29. Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Type (2025-2030)
Table 31. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Application (2019-2024)
Table 33. Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Application (2025-2030)
Table 35. North America Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2025-2030) & (US$ Million)
Table 50. GlaxoSmithKline (UK) Company Detail
Table 51. GlaxoSmithKline (UK) Business Overview
Table 52. GlaxoSmithKline (UK) Post-Traumatic Stress Disorder (PTSD) Product
Table 53. GlaxoSmithKline (UK) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024) & (US$ Million)
Table 54. GlaxoSmithKline (UK) Recent Development
Table 55. Pfizer (US) Company Detail
Table 56. Pfizer (US) Business Overview
Table 57. Pfizer (US) Post-Traumatic Stress Disorder (PTSD) Product
Table 58. Pfizer (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024) & (US$ Million)
Table 59. Pfizer (US) Recent Development
Table 60. Eli Lilly and Company (US) Company Detail
Table 61. Eli Lilly and Company (US) Business Overview
Table 62. Eli Lilly and Company (US) Post-Traumatic Stress Disorder (PTSD) Product
Table 63. Eli Lilly and Company (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024) & (US$ Million)
Table 64. Eli Lilly and Company (US) Recent Development
Table 65. Lundbeck A/S (Denmark) Company Detail
Table 66. Lundbeck A/S (Denmark) Business Overview
Table 67. Lundbeck A/S (Denmark) Post-Traumatic Stress Disorder (PTSD) Product
Table 68. Lundbeck A/S (Denmark) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024) & (US$ Million)
Table 69. Lundbeck A/S (Denmark) Recent Development
Table 70. Azevan Pharmaceuticals (US) Company Detail
Table 71. Azevan Pharmaceuticals (US) Business Overview
Table 72. Azevan Pharmaceuticals (US) Post-Traumatic Stress Disorder (PTSD) Product
Table 73. Azevan Pharmaceuticals (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024) & (US$ Million)
Table 74. Azevan Pharmaceuticals (US) Recent Development
Table 75. Marinus Pharmaceuticals, Inc. (US) Company Detail
Table 76. Marinus Pharmaceuticals, Inc. (US) Business Overview
Table 77. Marinus Pharmaceuticals, Inc. (US) Post-Traumatic Stress Disorder (PTSD) Product
Table 78. Marinus Pharmaceuticals, Inc. (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024) & (US$ Million)
Table 79. Marinus Pharmaceuticals, Inc. (US) Recent Development
Table 80. Tonix Pharmaceuticals Holding Corp. (US) Company Detail
Table 81. Tonix Pharmaceuticals Holding Corp. (US) Business Overview
Table 82. Tonix Pharmaceuticals Holding Corp. (US) Post-Traumatic Stress Disorder (PTSD) Product
Table 83. Tonix Pharmaceuticals Holding Corp. (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024) & (US$ Million)
Table 84. Tonix Pharmaceuticals Holding Corp. (US) Recent Development
Table 85. Bionomics (Australia) Company Detail
Table 86. Bionomics (Australia) Business Overview
Table 87. Bionomics (Australia) Post-Traumatic Stress Disorder (PTSD) Product
Table 88. Bionomics (Australia) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024) & (US$ Million)
Table 89. Bionomics (Australia) Recent Development
Table 90. Greenstone LLC (US) Company Detail
Table 91. Greenstone LLC (US) Business Overview
Table 92. Greenstone LLC (US) Post-Traumatic Stress Disorder (PTSD) Product
Table 93. Greenstone LLC (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024) & (US$ Million)
Table 94. Greenstone LLC (US) Recent Development
Table 95. Mylan NV (US) Company Detail
Table 96. Mylan NV (US) Business Overview
Table 97. Mylan NV (US) Post-Traumatic Stress Disorder (PTSD) Product
Table 98. Mylan NV (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024) & (US$ Million)
Table 99. Mylan NV (US) Recent Development
Table 100. Otsuka Pharmaceutical (Japan) Company Detail
Table 101. Otsuka Pharmaceutical (Japan) Business Overview
Table 102. Otsuka Pharmaceutical (Japan) Post-Traumatic Stress Disorder (PTSD) Product
Table 103. Otsuka Pharmaceutical (Japan) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024) & (US$ Million)
Table 104. Otsuka Pharmaceutical (Japan) Recent Development
Table 105. Prometheon Pharma (USA) Company Detail
Table 106. Prometheon Pharma (USA) Business Overview
Table 107. Prometheon Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Product
Table 108. Prometheon Pharma (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024) & (US$ Million)
Table 109. Prometheon Pharma (USA) Recent Development
Table 110. Ligand Pharma (USA) Company Detail
Table 111. Ligand Pharma (USA) Business Overview
Table 112. Ligand Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Product
Table 113. Ligand Pharma (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024) & (US$ Million)
Table 114. Ligand Pharma (USA) Recent Development
Table 115. Valenta Pharm (Russia) Company Detail
Table 116. Valenta Pharm (Russia) Business Overview
Table 117. Valenta Pharm (Russia) Post-Traumatic Stress Disorder (PTSD) Product
Table 118. Valenta Pharm (Russia) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024) & (US$ Million)
Table 119. Valenta Pharm (Russia) Recent Development
Table 120. Lycera Corp (US) Company Detail
Table 121. Lycera Corp (US) Business Overview
Table 122. Lycera Corp (US) Post-Traumatic Stress Disorder (PTSD) Product
Table 123. Lycera Corp (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024) & (US$ Million)
Table 124. Lycera Corp (US) Recent Development
Table 125. Archimedes (UK) Company Detail
Table 126. Archimedes (UK) Business Overview
Table 127. Archimedes (UK) Post-Traumatic Stress Disorder (PTSD) Product
Table 128. Archimedes (UK) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024) & (US$ Million)
Table 129. Archimedes (UK) Recent Development
Table 130. GMP Endotherapeutics (USA) Company Detail
Table 131. GMP Endotherapeutics (USA) Business Overview
Table 132. GMP Endotherapeutics (USA) Post-Traumatic Stress Disorder (PTSD) Product
Table 133. GMP Endotherapeutics (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024) & (US$ Million)
Table 134. GMP Endotherapeutics (USA) Recent Development
Table 135. Nuvo Pharmaceuticals (Canada) Company Detail
Table 136. Nuvo Pharmaceuticals (Canada) Business Overview
Table 137. Nuvo Pharmaceuticals (Canada) Post-Traumatic Stress Disorder (PTSD) Product
Table 138. Nuvo Pharmaceuticals (Canada) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024) & (US$ Million)
Table 139. Nuvo Pharmaceuticals (Canada) Recent Development
Table 140. Beijing Wansheng Pharmaceutical Company Detail
Table 141. Beijing Wansheng Pharmaceutical Business Overview
Table 142. Beijing Wansheng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product
Table 143. Beijing Wansheng Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024) & (US$ Million)
Table 144. Beijing Wansheng Pharmaceutical Recent Development
Table 145. Zhejiang Huahai Pharmaceutical Company Detail
Table 146. Zhejiang Huahai Pharmaceutical Business Overview
Table 147. Zhejiang Huahai Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product
Table 148. Zhejiang Huahai Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024) & (US$ Million)
Table 149. Zhejiang Huahai Pharmaceutical Recent Development
Table 150. Zhejiang Jianfeng Pharmaceutical Company Detail
Table 151. Zhejiang Jianfeng Pharmaceutical Business Overview
Table 152. Zhejiang Jianfeng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product
Table 153. Zhejiang Jianfeng Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024) & (US$ Million)
Table 154. Zhejiang Jianfeng Pharmaceutical Recent Development
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Post-Traumatic Stress Disorder (PTSD) Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Type: 2023 VS 2030
Figure 3. Cognitive Therapy Features
Figure 4. Exposure Therapy Features
Figure 5. Eye Movement Desensitization And Reprocessing (EMDR) Features
Figure 6. Antidepressants Features
Figure 7. Anti-Anxiety Medications Features
Figure 8. Prazosin Features
Figure 9. Global Post-Traumatic Stress Disorder (PTSD) Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Application: 2023 VS 2030
Figure 11. Children Case Studies
Figure 12. Adult Case Studies
Figure 13. Post-Traumatic Stress Disorder (PTSD) Report Years Considered
Figure 14. Global Post-Traumatic Stress Disorder (PTSD) Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Post-Traumatic Stress Disorder (PTSD) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Region: 2023 VS 2030
Figure 17. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Players in 2023
Figure 18. Global Top Post-Traumatic Stress Disorder (PTSD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post-Traumatic Stress Disorder (PTSD) as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Post-Traumatic Stress Disorder (PTSD) Revenue in 2023
Figure 20. North America Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Post-Traumatic Stress Disorder (PTSD) Market Share by Country (2019-2030)
Figure 22. United States Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Post-Traumatic Stress Disorder (PTSD) Market Share by Country (2019-2030)
Figure 26. Germany Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Share by Region (2019-2030)
Figure 34. China Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Post-Traumatic Stress Disorder (PTSD) Market Share by Country (2019-2030)
Figure 42. Mexico Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Share by Country (2019-2030)
Figure 46. Turkey Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. GlaxoSmithKline (UK) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
Figure 49. Pfizer (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
Figure 50. Eli Lilly and Company (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
Figure 51. Lundbeck A/S (Denmark) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
Figure 52. Azevan Pharmaceuticals (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
Figure 53. Marinus Pharmaceuticals, Inc. (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
Figure 54. Tonix Pharmaceuticals Holding Corp. (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
Figure 55. Bionomics (Australia) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
Figure 56. Greenstone LLC (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
Figure 57. Mylan NV (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
Figure 58. Otsuka Pharmaceutical (Japan) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
Figure 59. Prometheon Pharma (USA) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
Figure 60. Ligand Pharma (USA) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
Figure 61. Valenta Pharm (Russia) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
Figure 62. Lycera Corp (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
Figure 63. Archimedes (UK) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
Figure 64. GMP Endotherapeutics (USA) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
Figure 65. Nuvo Pharmaceuticals (Canada) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
Figure 66. Beijing Wansheng Pharmaceutical Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
Figure 67. Zhejiang Huahai Pharmaceutical Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
Figure 68. Zhejiang Jianfeng Pharmaceutical Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2019-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
